| MN | membranous nephropathy |
| PLA2R | phospholipase A2 receptor |
| iMN | idiopathic membranous nephropathy |
| sMN | secondary membranous nephropathy |
| SLE | systemic lupus erythematosus |
| AKI | acute kidney injury |
| eGFR | estimated glomerular filtration rate |
| ESRD | end-stage chronic kidney disease |
| NEP | neutral endopeptidase |
| APLA2R | anti-M-type phospholipase A2-receptor antibody |
| IHC | immunohistochemistry |
| IF | immunofluorescence |
| THSD7A | thrombospondin type-1 domain-containing 7A |
| EXT1 | Exostosin 1 |
| EXT2 | Exostosin 2 |
| NELL-1 | neural epidermal growth factor-like 1 protein |
| Sema3B | Semaphorin 3B |
| NCAM1 | neural cell adhesion molecule 1 |
| MLN | membranous lupus nephritis |
| GBM | glomerular basement membrane |
| CNTN1 | contactin 1 |
| PCDH7 | protocadherin 7 |
| HTRA1 | serine protease HTRA1 |
| TGFBR3 | transforming growth factor beta receptor 3 |
| NTNG1 | netrin G1 |
| FAT1 | protocadherin FAT1 |
| MS/MS | microdissection and tandem mass spectrometry |
| NDNF | neuron-derived neurotrophic factor |
| PCSK6 | proprotein convertase subtilisin/kexin type 6 |
| PM2.5 | fine particulate matter with a diameter of 2.5 micrometers or less |
| FSGS | focal segmental glomerulosclerosis |